En español

Menu

Home
Drugs of Abuse

Quick Links

Related Topics

Quick Links

Publications

Quick Links

Research

Quick Links

Funding

Quick Links

News

Quick Links

About NIDA

Quick Links

COVID-19 is an emerging, rapidly evolving situation.

Get the latest information from CDC (Coronavirus.gov) | NIH Resources | NIDA Resources

NIDA Notes Articles: Comorbidity
NIDA Notes Category Graphic

Interim Buprenorphine Alleviates Psychiatric Symptoms in Waitlisted OUD Patients

March 2019
Interim treatment with buprenorphine significantly improved the psychiatric symptoms of people awaiting comprehensive treatment for opioid use disorder (OUD). Buprenorphine treatment, even without concurrent psychosocial counseling, may help patients with no, or delayed, access to comprehensive OUD treatment.

NIDA Notes Category Graphic

Integrated Intervention Benefits People Who Inject Drugs and Have HIV

November 2018
In this international trial, participants who received the intervention engaged in HIV treatment, achieved viral suppression at higher rates, and died at half the rate of participants in a control group. En Español

NIDA Notes Category Graphic

Slow-Release Amphetamine Medication Benefits Patients With Comorbid Cocaine Addiction and ADHD

August 2016
Treatment with an extended-release stimulant medication plus cognitive behavioral therapy was associated with reductions in cocaine use and in attention-deficit/hyperactivity disorder symptoms in patients with both disorders.

NIDA Notes

Categories

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics